Should Duchenne Muscular Dystrophy Join Newborn Screening List?
Published Date: 8/14/2025
Notice
Summary
HRSA is thinking about adding Duchenne Muscular Dystrophy (DMD) to the list of diseases newborns get screened for right after birth. This change would help babies with DMD get diagnosed early, and health plans would cover the screening without extra costs. HRSA wants your thoughts on how useful early screening is, if states can do it, and if good treatments are ready.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
No‑Cost Newborn DMD Screening If Added
HRSA is considering adding Duchenne Muscular Dystrophy (DMD) to the Recommended Uniform Screening Panel (RUSP). If DMD is added, non‑grandfathered health plans would be required to cover the newborn screening under HRSA-supported guidelines without cost-sharing (for example, no co-payments or co‑insurance) for infants screened shortly after birth.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in